NovoCure Limited is an oncology company that develops and manufactures tumor treating fields (TTFields) devices for the treatment of solid tumor cancers. Their devices include Optune for glioblastoma and Optune Lua for malignant pleural mesothelioma. NovoCure has ongoing or completed clinical trials for various cancer types and is headquartered in Saint Helier, Jersey.